5α-Reductase-2 Deficiency: Clinical Findings, Endocrine Pitfalls, and Genetic Features in a Large Italian Cohort

Silvano Bertelloni, Fulvia Baldinotti, Gianni Russo, Paolo Ghirri, Eleonora Dati, Angela Michelucci, Francesca Moscuzza, Silvia Meroni, Ilaria Colombo, Maria R. Sessa, Giampiero I. Baroncelli

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Clinical records (n = 24) with an established diagnosis of 5α-reductase-2 deficiency were reviewed. A previous misdiagnosis was present in about 70% (period from first observation to definitive diagnosis: 9.1 ± 10.8 years), and in 8 children gonadal removal was performed before certain diagnosis. Initial sex assignment was female in 16/24 (67%) and male in 8/24 (33%) cases. After diagnosis, sex re-assignment was performed in 5 babies (4 girls to male sex; 1 boy to female sex). Baseline testosterone/DHT ratio was diagnostic in 6/12 subjects (first months of life n = 4; puberty n = 2), while post-hCG testosterone/DHT ratio was diagnostic in all tested individuals (choosing both the cut-off value 15 or 10). Eighteen different mutations in the steroid-5α-reductase-2 (SRD5A2) gene were identified, 5 of which have never been reported. In conclusion, a time lag exists before the diagnosis of 5α-reductase-2 deficiency is established; sex assignment and gonadal removal may be performed before certain diagnosis. Sex re-assignment is usually female to male, but the contrary may occur. A large variability in clinical phenotypes and genetic mutations was present in this cohort. Accurate endocrine evaluation is recommended in babies possibly affected by 5α-reductase-2 deficiency, since the use of appropriate cut-off values of testosterone/DHT ratio after hCG stimulation may permit to select individuals for SRD5A2 gene analysis. A genotype-phenotype correlation was not found in this study.

Original languageEnglish
Pages (from-to)28-36
Number of pages9
JournalSexual Development
DOIs
Publication statusAccepted/In press - Apr 13 2016
Externally publishedYes

Fingerprint

Oxidoreductases
Testosterone
Steroids
Mutation
Genetic Association Studies
Puberty
Diagnostic Errors
Genes
Observation
Phenotype

Keywords

  • 46,XY disorders of sex development
  • 5α-Reductase-2 deficiency
  • Molecular genetics
  • SRD5A2 gene
  • Testosterone/dihydrotestosterone ratio#

ASJC Scopus subject areas

  • Developmental Biology
  • Embryology
  • Endocrinology, Diabetes and Metabolism

Cite this

Bertelloni, S., Baldinotti, F., Russo, G., Ghirri, P., Dati, E., Michelucci, A., ... Baroncelli, G. I. (Accepted/In press). 5α-Reductase-2 Deficiency: Clinical Findings, Endocrine Pitfalls, and Genetic Features in a Large Italian Cohort. Sexual Development, 28-36. https://doi.org/10.1159/000445090

5α-Reductase-2 Deficiency : Clinical Findings, Endocrine Pitfalls, and Genetic Features in a Large Italian Cohort. / Bertelloni, Silvano; Baldinotti, Fulvia; Russo, Gianni; Ghirri, Paolo; Dati, Eleonora; Michelucci, Angela; Moscuzza, Francesca; Meroni, Silvia; Colombo, Ilaria; Sessa, Maria R.; Baroncelli, Giampiero I.

In: Sexual Development, 13.04.2016, p. 28-36.

Research output: Contribution to journalArticle

Bertelloni, S, Baldinotti, F, Russo, G, Ghirri, P, Dati, E, Michelucci, A, Moscuzza, F, Meroni, S, Colombo, I, Sessa, MR & Baroncelli, GI 2016, '5α-Reductase-2 Deficiency: Clinical Findings, Endocrine Pitfalls, and Genetic Features in a Large Italian Cohort', Sexual Development, pp. 28-36. https://doi.org/10.1159/000445090
Bertelloni, Silvano ; Baldinotti, Fulvia ; Russo, Gianni ; Ghirri, Paolo ; Dati, Eleonora ; Michelucci, Angela ; Moscuzza, Francesca ; Meroni, Silvia ; Colombo, Ilaria ; Sessa, Maria R. ; Baroncelli, Giampiero I. / 5α-Reductase-2 Deficiency : Clinical Findings, Endocrine Pitfalls, and Genetic Features in a Large Italian Cohort. In: Sexual Development. 2016 ; pp. 28-36.
@article{cb4fdad37f5e48dea743edeef1d25637,
title = "5α-Reductase-2 Deficiency: Clinical Findings, Endocrine Pitfalls, and Genetic Features in a Large Italian Cohort",
abstract = "Clinical records (n = 24) with an established diagnosis of 5α-reductase-2 deficiency were reviewed. A previous misdiagnosis was present in about 70{\%} (period from first observation to definitive diagnosis: 9.1 ± 10.8 years), and in 8 children gonadal removal was performed before certain diagnosis. Initial sex assignment was female in 16/24 (67{\%}) and male in 8/24 (33{\%}) cases. After diagnosis, sex re-assignment was performed in 5 babies (4 girls to male sex; 1 boy to female sex). Baseline testosterone/DHT ratio was diagnostic in 6/12 subjects (first months of life n = 4; puberty n = 2), while post-hCG testosterone/DHT ratio was diagnostic in all tested individuals (choosing both the cut-off value 15 or 10). Eighteen different mutations in the steroid-5α-reductase-2 (SRD5A2) gene were identified, 5 of which have never been reported. In conclusion, a time lag exists before the diagnosis of 5α-reductase-2 deficiency is established; sex assignment and gonadal removal may be performed before certain diagnosis. Sex re-assignment is usually female to male, but the contrary may occur. A large variability in clinical phenotypes and genetic mutations was present in this cohort. Accurate endocrine evaluation is recommended in babies possibly affected by 5α-reductase-2 deficiency, since the use of appropriate cut-off values of testosterone/DHT ratio after hCG stimulation may permit to select individuals for SRD5A2 gene analysis. A genotype-phenotype correlation was not found in this study.",
keywords = "46,XY disorders of sex development, 5α-Reductase-2 deficiency, Molecular genetics, SRD5A2 gene, Testosterone/dihydrotestosterone ratio#",
author = "Silvano Bertelloni and Fulvia Baldinotti and Gianni Russo and Paolo Ghirri and Eleonora Dati and Angela Michelucci and Francesca Moscuzza and Silvia Meroni and Ilaria Colombo and Sessa, {Maria R.} and Baroncelli, {Giampiero I.}",
year = "2016",
month = "4",
day = "13",
doi = "10.1159/000445090",
language = "English",
pages = "28--36",
journal = "Sexual Development",
issn = "1661-5425",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - 5α-Reductase-2 Deficiency

T2 - Clinical Findings, Endocrine Pitfalls, and Genetic Features in a Large Italian Cohort

AU - Bertelloni, Silvano

AU - Baldinotti, Fulvia

AU - Russo, Gianni

AU - Ghirri, Paolo

AU - Dati, Eleonora

AU - Michelucci, Angela

AU - Moscuzza, Francesca

AU - Meroni, Silvia

AU - Colombo, Ilaria

AU - Sessa, Maria R.

AU - Baroncelli, Giampiero I.

PY - 2016/4/13

Y1 - 2016/4/13

N2 - Clinical records (n = 24) with an established diagnosis of 5α-reductase-2 deficiency were reviewed. A previous misdiagnosis was present in about 70% (period from first observation to definitive diagnosis: 9.1 ± 10.8 years), and in 8 children gonadal removal was performed before certain diagnosis. Initial sex assignment was female in 16/24 (67%) and male in 8/24 (33%) cases. After diagnosis, sex re-assignment was performed in 5 babies (4 girls to male sex; 1 boy to female sex). Baseline testosterone/DHT ratio was diagnostic in 6/12 subjects (first months of life n = 4; puberty n = 2), while post-hCG testosterone/DHT ratio was diagnostic in all tested individuals (choosing both the cut-off value 15 or 10). Eighteen different mutations in the steroid-5α-reductase-2 (SRD5A2) gene were identified, 5 of which have never been reported. In conclusion, a time lag exists before the diagnosis of 5α-reductase-2 deficiency is established; sex assignment and gonadal removal may be performed before certain diagnosis. Sex re-assignment is usually female to male, but the contrary may occur. A large variability in clinical phenotypes and genetic mutations was present in this cohort. Accurate endocrine evaluation is recommended in babies possibly affected by 5α-reductase-2 deficiency, since the use of appropriate cut-off values of testosterone/DHT ratio after hCG stimulation may permit to select individuals for SRD5A2 gene analysis. A genotype-phenotype correlation was not found in this study.

AB - Clinical records (n = 24) with an established diagnosis of 5α-reductase-2 deficiency were reviewed. A previous misdiagnosis was present in about 70% (period from first observation to definitive diagnosis: 9.1 ± 10.8 years), and in 8 children gonadal removal was performed before certain diagnosis. Initial sex assignment was female in 16/24 (67%) and male in 8/24 (33%) cases. After diagnosis, sex re-assignment was performed in 5 babies (4 girls to male sex; 1 boy to female sex). Baseline testosterone/DHT ratio was diagnostic in 6/12 subjects (first months of life n = 4; puberty n = 2), while post-hCG testosterone/DHT ratio was diagnostic in all tested individuals (choosing both the cut-off value 15 or 10). Eighteen different mutations in the steroid-5α-reductase-2 (SRD5A2) gene were identified, 5 of which have never been reported. In conclusion, a time lag exists before the diagnosis of 5α-reductase-2 deficiency is established; sex assignment and gonadal removal may be performed before certain diagnosis. Sex re-assignment is usually female to male, but the contrary may occur. A large variability in clinical phenotypes and genetic mutations was present in this cohort. Accurate endocrine evaluation is recommended in babies possibly affected by 5α-reductase-2 deficiency, since the use of appropriate cut-off values of testosterone/DHT ratio after hCG stimulation may permit to select individuals for SRD5A2 gene analysis. A genotype-phenotype correlation was not found in this study.

KW - 46,XY disorders of sex development

KW - 5α-Reductase-2 deficiency

KW - Molecular genetics

KW - SRD5A2 gene

KW - Testosterone/dihydrotestosterone ratio#

UR - http://www.scopus.com/inward/record.url?scp=84963606402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963606402&partnerID=8YFLogxK

U2 - 10.1159/000445090

DO - 10.1159/000445090

M3 - Article

AN - SCOPUS:84963606402

SP - 28

EP - 36

JO - Sexual Development

JF - Sexual Development

SN - 1661-5425

ER -